This Promising New Alzheimer's Study Could Unlock a Massive Growth Opportunity for Novo Nordisk and Eli LillyThe Motley Fool • 01/08/25
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pactMarket Watch • 01/08/25
Valo Health and Novo Nordisk expand collaboration to discover and develop novel treatments for cardiometabolic diseasesGlobeNewsWire • 01/08/25
Trump's Danish Tariff Threat Means News Uncertainty for Ozempic Drugmaker Novo NordiskBarrons • 01/07/25
Seattle genomics startup Variant Bio signs deal with Novo Nordisk worth up to $50MGeekWire • 01/07/25
Brokers Suggest Investing in Novo Nordisk (NVO): Read This Before Placing a BetZacks Investment Research • 01/07/25
Novo Nordisk's Sponsorship Deals With UK Pharmacies Linked To Weight-Loss Drugs Raise Ethical ConcernsBenzinga • 01/07/25
Novo Nordisk Vs. Eli Lilly: Obesity Makes Their Future Bright, But One Of Them Has More PotentialSeeking Alpha • 01/06/25
4-Factor Dividend Growth Strategy - Cold Winter Air Creeps Into The PortfolioSeeking Alpha • 01/04/25
Lilly and Novo Went Head-to-Head Over Weight-Loss Drugs in 2024. There's a Clear Winner.Barrons • 12/31/24
Billionaire Philippe Laffont Is Selling Artificial Intelligence Champion Nvidia and Piling Into These Two Industry LeadersThe Motley Fool • 12/29/24
Novo Nordisk (NVO) Stock Drops Despite Market Gains: Important Facts to NoteZacks Investment Research • 12/24/24